These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

497 related articles for article (PubMed ID: 31780025)

  • 21. The effects of nano-curcumin supplementation on glycemic control, blood pressure, lipid profile, and insulin resistance in patients with the metabolic syndrome: A randomized, double-blind clinical trial.
    Bateni Z; Rahimi HR; Hedayati M; Afsharian S; Goudarzi R; Sohrab G
    Phytother Res; 2021 Jul; 35(7):3945-3953. PubMed ID: 33851448
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chromium Supplementation and the Effects on Metabolic Status in Women with Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial.
    Jamilian M; Asemi Z
    Ann Nutr Metab; 2015; 67(1):42-8. PubMed ID: 26279073
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A Trial on The Effects of Magnesium-Zinc-Calcium-Vitamin D Co-Supplementation on Glycemic Control and Markers of Cardio-Metabolic Risk in Women with Polycystic Ovary Syndrome.
    Jamilian M; Maktabi M; Asemi Z
    Arch Iran Med; 2017 Oct; 20(10):640-645. PubMed ID: 29137465
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effects of vitamin D supplementation on metabolic profiles and gene expression of insulin and lipid metabolism in infertile polycystic ovary syndrome candidates for in vitro fertilization.
    Dastorani M; Aghadavod E; Mirhosseini N; Foroozanfard F; Zadeh Modarres S; Amiri Siavashani M; Asemi Z
    Reprod Biol Endocrinol; 2018 Oct; 16(1):94. PubMed ID: 30286768
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of Chromium and Carnitine Co-supplementation on Body Weight and Metabolic Profiles in Overweight and Obese Women with Polycystic Ovary Syndrome: a Randomized, Double-Blind, Placebo-Controlled Trial.
    Jamilian M; Foroozanfard F; Kavossian E; Kia M; Aghadavod E; Amirani E; Asemi Z
    Biol Trace Elem Res; 2020 Feb; 193(2):334-341. PubMed ID: 30977089
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical and Metabolic Response to Selenium Supplementation in Pregnant Women at Risk for Intrauterine Growth Restriction: Randomized, Double-Blind, Placebo-Controlled Trial.
    Mesdaghinia E; Rahavi A; Bahmani F; Sharifi N; Asemi Z
    Biol Trace Elem Res; 2017 Jul; 178(1):14-21. PubMed ID: 27928721
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Effects of Vitamin D Supplementation on Metabolic Status of Patients with Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial.
    Maktabi M; Chamani M; Asemi Z
    Horm Metab Res; 2017 Jul; 49(7):493-498. PubMed ID: 28679140
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of metformin compared with hypocaloric diet on serum C-reactive protein level and insulin resistance in obese and overweight women with polycystic ovary syndrome.
    Esfahanian F; Zamani MM; Heshmat R; Moini nia F
    J Obstet Gynaecol Res; 2013 Apr; 39(4):806-13. PubMed ID: 23279603
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Meta-analysis of the effects of probiotic supplementation on glycemia, lipidic profiles, weight loss and C-reactive protein in women with polycystic ovarian syndrome.
    Liao D; Zhong C; Li C; Mo L; Liu Y
    Minerva Med; 2018 Dec; 109(6):479-487. PubMed ID: 30256077
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Metabolic response to omega-3 fatty acid supplementation in patients with diabetic nephropathy: A randomized, double-blind, placebo-controlled trial.
    Soleimani A; Taghizadeh M; Bahmani F; Badroj N; Asemi Z
    Clin Nutr; 2017 Feb; 36(1):79-84. PubMed ID: 26611718
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Relationship between the triglyceride/high-density lipoprotein-cholesterol ratio, insulin resistance index and cardiometabolic risk factors in women with polycystic ovary syndrome].
    Roa Barrios M; Arata-Bellabarba G; Valeri L; Velázquez-Maldonado E
    Endocrinol Nutr; 2009 Feb; 56(2):59-65. PubMed ID: 19627713
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A pilot study of the effects of chromium picolinate supplementation on serum fetuin-A, metabolic and inflammatory factors in patients with nonalcoholic fatty liver disease: A double-blind, placebo-controlled trial.
    Moradi F; Kooshki F; Nokhostin F; Khoshbaten M; Bazyar H; Pourghassem Gargari B
    J Trace Elem Med Biol; 2021 Jan; 63():126659. PubMed ID: 33045675
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of green coffee aqueous extract supplementation on glycemic indices, lipid profile, CRP, and malondialdehyde in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled trial.
    Khalili-Moghadam S; Hedayati M; Golzarand M; Mirmiran P
    Front Nutr; 2023; 10():1241844. PubMed ID: 38035358
    [TBL] [Abstract][Full Text] [Related]  

  • 34. DASH diet, insulin resistance, and serum hs-CRP in polycystic ovary syndrome: a randomized controlled clinical trial.
    Asemi Z; Esmaillzadeh A
    Horm Metab Res; 2015 Mar; 47(3):232-8. PubMed ID: 24956415
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of curcumin supplementation on blood glucose, insulin resistance and androgens in patients with polycystic ovary syndrome: A randomized double-blind placebo-controlled clinical trial.
    Heshmati J; Moini A; Sepidarkish M; Morvaridzadeh M; Salehi M; Palmowski A; Mojtahedi MF; Shidfar F
    Phytomedicine; 2021 Jan; 80():153395. PubMed ID: 33137599
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of Curcumin on metabolic parameters and androgen level in women with polycystic ovary syndrome: a randomized controlled trial.
    Ghanbarzadeh-Ghashti N; Ghanbari-Homaie S; Shaseb E; Abbasalizadeh S; Mirghafourvand M
    BMC Endocr Disord; 2023 Feb; 23(1):40. PubMed ID: 36788534
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Effect of Magnesium and Vitamin E Co-Supplementation on Glycemic Control and Markers of Cardio-Metabolic Risk in Women with Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial.
    Jamilian M; Sabzevar NK; Asemi Z
    Horm Metab Res; 2019 Feb; 51(2):100-105. PubMed ID: 30286483
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Metabolic response to folate supplementation in overweight women with polycystic ovary syndrome: a randomized double-blind placebo-controlled clinical trial.
    Asemi Z; Karamali M; Esmaillzadeh A
    Mol Nutr Food Res; 2014 Jul; 58(7):1465-73. PubMed ID: 24828019
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effects of folate supplementation on inflammatory factors and biomarkers of oxidative stress in overweight and obese women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled clinical trial.
    Bahmani F; Karamali M; Shakeri H; Asemi Z
    Clin Endocrinol (Oxf); 2014 Oct; 81(4):582-7. PubMed ID: 24628390
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High sensitive serum C-reactive protein and its relationship with other cardiovascular risk factors in normoinsulinemic polycystic ovary patients without metabolic syndrome.
    Verit FF
    Arch Gynecol Obstet; 2010 Jun; 281(6):1009-14. PubMed ID: 19771438
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.